Healing October 7th: Using MDMA for PTSD in Israel

Study finds among outpatients with mild to moderate COVID-19, treatment with fluvoxamine does not reduce duration of symptoms

Researchers investigate the effects of high-dose fluvoxamine among patients with mild-to-moderate COVID-19.

November 22, 2023

Gilead tracks five years of HIV grant giving in hard-hit US South, and doubles down on new approaches

Gilead Sciences is now halfway through its 10-year pledge in the US southern states to tackle HIV through community grants, and looking back while also

August 18, 2023

Xylazine-Laced Fentanyl Overdose: ‘Make Sure They’re Breathing’

With rising reports of the veterinary sedative xylazine — also known as “tranq” — being mixed in with illicit fentanyl, physicians should be aware that

March 1, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.